7Baggers

AquaBounty Technologies, Inc
(NASDAQ:AQB) 

AQB stock logo

AquaBounty Technologies, Inc., a biotechnology company, focuses on improving productivity in the commercial aquaculture industry in the United States and Canada. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs,...

Full Time Employees: 71
CEO: Sylvia A. Wulf  
Sector: Consumer Defensive
Industry: Farm Products

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 
                                          
      costs and expenses
                                          
      sales and marketing
        6,613 3,467 44,167 79,702 63,963 211,530 191,862 194,254 198,285 354,899 186,393 349,917 247,572 192,410 201,838 548,881 318,635 201,560 143,646 137,434 50,788 327,386 206,256 103,390 71,991 74,688 64,971 76,381 81,647 191,864 195,947 202,910 208,288  
      general and administrative
    621,566 -729,465 1,412,112 1,768,596 1,560,436 1,294,714 1,887,814 3,446,560 2,500,557 4,604,993 2,334,861 3,067,533 3,000,482 2,313,898 2,264,755 2,831,930 2,376,236 2,561,592 2,177,153 2,578,958 1,785,510 1,743,835 1,722,874 1,693,544 1,637,190 -766,562 2,346,754 3,106,374 2,036,493 1,548,682 1,852,362 1,827,991 1,386,873 1,610,308 1,382,380 950,348 1,120,788  
      total costs and expenses
    621,566 -2,016,878 1,480,659 3,294,348 1,260,163 47,904,308 2,409,131 49,700,069 11,425,606 8,870,291 6,806,984 7,231,059 6,880,924 6,563,518 6,190,042 6,640,245 6,066,687 6,460,029 7,270,340 5,406,808 4,159,420 6,088,449 3,680,921 3,507,949 3,098,174 3,450,006 2,999,592 4,062,205 2,853,578 2,424,299 2,730,965 2,832,481 2,462,569 2,656,697 2,439,230 2,140,352 2,049,098  
      operating income
    -621,566 2,016,878 -1,480,659 -3,294,348 -1,260,163 174,268,658 -2,361,319 -49,519,887 -10,948,338 -8,317,041 -6,073,851 -6,442,629 -6,483,078 -6,112,583 -5,536,610 -5,570,539 -5,103,806 -6,042,359 -6,814,943 -5,179,415 -4,085,048 -6,038,252 -3,613,158 -3,504,999 -3,091,421 -3,403,639 -2,999,592 -4,019,719 -2,755,693 -2,417,714 -2,720,027 -2,784,583 -2,443,472 -2,656,697 -2,439,230 -2,087,074 -2,049,098  
      yoy
    -50.68% -98.84% -37.30% -93.35% -88.49% -2195.32% -61.12% 668.63% 68.88% 36.06% 9.70% 15.66% 27.02% 1.16% -18.76% 7.55% 24.94% 0.07% 88.61% 47.77% 32.14% 77.41% 20.45% -12.80% 12.18% 40.78% 10.28% 44.36% 12.78% -9.00% 11.51% 33.42% 19.25%      
      qoq
    -130.82% -236.21% -55.05% 161.42% -100.72% -7480.14% -95.23% 352.31% 31.64% 36.93% -5.72% -0.62% 6.06% 10.40% -0.61% 9.14% -15.53% -11.34% 31.58% 26.79% -32.35% 67.12% 3.09% 13.38% -9.17% 13.47% -25.38% 45.87% 13.98% -11.11% -2.32% 13.96% -8.03% 8.92% 16.87% 1.85%   
      other income
         -11,014 -12,063 -4,378 -1,347 225 -516 -328 63,284 112,165 168,796 109,191 67,368 52,177 29,593 28,888 4,961 197 1,705 -538 -1,152 10,935 -697 -1,348 5,100 -1,466 -1,832 -1,868 -2,073 -2,086 -1,392 -1,109 -1,365  
      interest expense
    -299,985 18,183  -90,585 -133,650 -55,529 -1,030,949 -989,976 -208,563 -108,158 -63,746 -65,789 -66,274 -68,882 -72,313 -74,694 -75,288 -77,939 -79,489 -80,210 -78,804 -78,840 -38,335 -18,147 -17,045 -17,505 -17,933 -14,212 -13,338 -6,403 -5,169 -5,283 -5,402 -5,407 -5,597 -5,253 -5,280  
      loan forgiveness
        2,008,046                                  
      other expense
    -3,250 -2,269 -3,671 -2,979 -4,469                                  
      total other income
    -303,235 15,914 -3,671 -93,564 1,869,927     -107,933 -64,262 -66,117  43,283 96,483 34,497 -7,920 -25,762 -49,896 -51,322 -73,843 -78,643 -36,630 -18,685 -18,197 -15,118 -18,630 -7,012 -8,238 -6,381 -7,001 3,434 -6,315 -6,552 -6,989 -6,362 -6,645  
      income from continuing operations
    -924,801    609,764                                  
      loss from discontinued operations
    -275,269    -208,629                                  
      net income
    -1,200,070 -14,137,812 -1,380,773 -3,373,037 401,135 214,269,480 -3,404,331 -50,514,241 -11,158,248 -8,424,974 -6,138,113 -6,508,746 -6,486,068 -6,069,300 -5,440,127 -5,536,042 -5,111,726 -6,068,121 -6,864,839 -5,230,737 -4,158,891 -6,116,895 -3,649,788 -3,523,684 -3,109,618 -3,418,757 -3,018,222 -4,026,731 -2,763,931 -2,424,095 -2,727,028 -2,781,149 -2,449,787 -2,663,249 -2,446,219 -2,093,436 -2,055,743  
      yoy
    -399.17% -106.60% -59.44% -93.32% -103.59% -2643.27% -44.54% 676.10% 72.03% 38.81% 12.83% 17.57% 26.89% 0.02% -20.75% 5.84% 22.91% -0.80% 88.09% 48.45% 33.74% 78.92% 20.93% -12.49% 12.51% 41.03% 10.68% 44.79% 12.82% -8.98% 11.48% 32.85% 19.17%      
      qoq
    -91.51% 923.91% -59.06% -940.87% -99.81% -6394.03% -93.26% 352.71% 32.44% 37.26% -5.69% 0.35% 6.87% 11.57% -1.73% 8.30% -15.76% -11.61% 31.24% 25.77% -32.01% 67.60% 3.58% 13.32% -9.04% 13.27% -25.05% 45.69% 14.02% -11.11% -1.95% 13.53% -8.02% 8.87% 16.85% 1.83%   
      other comprehensive income
                                          
      foreign currency translation gain
     172,057.25   688,229 -26,985.25 65,701 -57,335 -116,307   111,346 4,427 -93,605.5 -303,725 -153,602 82,905     222,895 86,491 165,501 -381,985         29,304 34,933 22,437   
      comprehensive income
    -1,200,070    1,089,364                                  
      basic and diluted net income per share
                                          
      from continuing operations
    -0.2 0.53 -0.38 -0.87 0.16                                  
      from discontinued operations
    -0.06 -4.18 0.02  -0.05                                  
      total basic and diluted net income per share
    -0.26    0.1                                  
      weighted-average number of common shares
                                          
      - basic and diluted
    4,564,479 968,114 3,877,695 3,872,587 3,866,733                                  
      research and development
         -33,088 52,093 64,502 119,789 218,291 184,221 178,394 122,917 307,902 220,598 208,292 167,189 633,209 580,346 431,373 500,620 701,731 458,462 635,655 568,762 435,929 446,582 813,449 663,481 795,167 804,758 880,822 977,817 854,525 860,903 936,317 720,022  
      asset impairment
     321,853.25 68,547 1,525,752                                   
      loss from continuing operations
     2,032,792 -1,484,330 -3,387,912                                   
      income from discontinued operations
     -22,549.25 103,557 14,875                                   
      comprehensive loss
     -14,137,812 -1,380,773 -3,373,037  214,660,186 -3,338,630 -50,571,576 -11,274,555 -8,291,234 -6,276,315 -6,397,400 -6,481,641 -5,996,166 -5,711,482 -5,567,848 -5,142,886 -6,080,846 -6,995,377 -5,155,843 -4,078,852 -5,894,000 -3,563,297 -3,358,183 -3,491,603 -3,338,179 -3,057,114 -3,941,943 -2,676,380 -2,671,179 -2,642,317 -2,866,960 -2,561,905 -2,633,945 -2,411,286 -2,070,999 -2,070,029  
      total basic and diluted net loss per share
     -3.65 -0.36 -0.87                                   
      gain on asset sales
        -306,886                                  
      revenues
                                          
      product revenues
         176,315.5 47,812 180,182 477,268 553,250 733,133 788,430 397,846 450,935 653,432 1,069,706 962,881 417,670 455,397 227,393 74,372 50,197 67,763 2,950 6,753 46,367  42,486 97,885 6,585 10,938 47,898 19,097   53,278   
      product costs
         1,635,609.25 425,057 1,641,083 4,476,297 3,835,477 4,096,040 3,790,878 3,559,240 3,586,819 3,518,296 3,250,106 3,275,690 3,072,818 4,311,003 1,847,596 1,554,655     30,151.25  38,992 81,613 5,762 8,874 47,287 16,232   50,777   
      long-lived asset impairment
         53,181,652  44,468,222 4,265,000                              
      total other expense
         -66,543 -1,043,012 -994,354 -209,910    -2,990                          
      total other comprehensive income
         -26,985.25 65,701 -57,335 -116,307   111,346 4,427 73,134 -271,355 -31,806 -31,160 -12,725 -130,538 74,894 80,039 222,895 86,491 165,501 -381,985 80,578 -38,892 84,788 87,551 -247,084 84,711 -85,811  29,304 34,933 22,437   
      basic and diluted net loss per share
         -4.218 -0.88 -13.08 -2.9 -2.19 -1.6 -0.09 -0.09 -0.08 -0.08 -0.08 -0.07 -0.08 -0.1 -0.07 -0.06 -0.078 -0.09 -0.11 -0.11 -0.125 -0.14 -0.19 -0.18 -0.16 -0.21 -0.22 -0.21 -0.3 -0.28 -0.24 -0.24  
      -basic and diluted
         964,660.5 3,865,778 3,860,487                               
      other comprehensive income:
                                          
      weighted-average number of common shares -
                                          
      basic and diluted
     3,873,797    3,860,454   3,849,248 3,844,239 3,846,622 71,344,025 71,169,277 71,068,515 71,070,196 71,068,671 71,004,454 69,428,061 71,025,738 71,021,141 64,550,920  38,911,054 32,097,992 27,116,754  21,604,072 21,313,055 15,687,681  12,848,376 12,787,761 11,940,874  8,895,094 8,892,213 8,400,795  
      other comprehensive loss:
                                          
      foreign currency translation loss
             -5,607.25 -138,202                      -112,118    -14,286  
      unrealized gain on marketable securities
                 10,025.25 32,370 121,796                       
      total other comprehensive loss
             -5,607.25 -138,202                      -112,118    -14,286  
      unrealized loss on marketable securities
                    -114,065                      
      foreign currency
                     42,478 -136,670 65,924                   
      unrealized gains
                     3,775.5 6,132 8,970                   
      foreign currency translation income
                        80,039     33,362 -38,892 84,788 87,551 -28,304.5 84,711 -85,811       
      production costs
                         3,441,323 1,355,939 1,041,316 841,434              
      gain on disposal of equipment
                             2,137  8,548  1,488  10,585 1,160      
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 
                                            
        assets
                                            
        current assets:
                                            
        cash
      440,678                                      
        prepaid expenses and other current assets
      158,352 266,862 519,027 3,115,868 1,207,023 292,018 1,089,013 798,545 1,262,582 1,700,273 3,718,087 3,375,949 2,290,836 2,133,583 4,041,029 4,447,399 1,695,159 1,536,484 1,197,830 1,285,168 470,961 358,692 820,193 696,455 364,700 391,162 391,561 555,946 261,176 315,969 315,383 394,594 156,973 527,322 245,242 352,772 264,228 72,983 
        current assets held for sale
      9,634,337 9,552,454 5,000 100,000 4,148,500 10,819,909                                 
        total current assets
      10,233,367 10,320,611 1,475,461 3,945,437 6,721,851 11,342,289 37,342,571 36,737,831 4,327,136 11,637,745 22,427,577 48,571,845 77,443,586 106,048,732 133,153,900 154,609,571 182,245,790 193,025,163 200,231,734 207,979,292 213,476,868 97,681,907 42,741,063 13,264,991 17,031,276 4,477,153 7,367,611 11,289,848 8,200,192 3,510,617 1,513,556 4,109,977 7,352,236 1,389,894 5,274,385 8,596,440 25,941,082 3,573,001 
        right of use assets
      15,480 22,982 30,330 37,531 44,589 51,509 58,291 265,923 273,575 281,104 204,396 205,565 206,734 222,856 238,699 254,221 269,426 284,320 298,966 313,318 327,386 341,997 356,788 371,292 385,519 399,477 413,235 426,735 454,890          
        total assets
      10,248,847 10,343,593 24,173,791 26,650,968 29,434,440 34,061,798 117,785,364 127,437,408 176,184,057 187,551,428 192,546,335 210,215,977 206,287,857 213,840,772 222,685,208 220,139,761 221,647,755 228,435,992 231,353,109 238,272,450 242,535,933 125,776,503 69,596,179 38,495,395 41,414,178 30,233,739 32,959,366 36,774,715 33,029,956 27,671,060 26,043,274 28,259,714 31,487,566 23,731,758 25,295,552 26,907,790 28,549,094 5,708,834 
        liabilities and stockholders' equity
                                            
        current liabilities:
                                            
        accounts payable and accrued liabilities
      227,798 337,038 3,069,766 3,317,732 10,079,353 10,104,853 11,751,477 12,875,295 13,106,204 12,991,819 9,895,839 20,875,113 10,836,269 12,000,592 15,544,254 6,883,125 2,913,028 4,317,615 1,953,716 1,980,365 1,555,066 1,760,103 2,116,877 1,764,124 1,834,685 1,462,809 1,102,621 1,977,030 958,058 845,323 1,483,657 1,168,875 2,092,927 2,666,855 1,602,396 949,495 784,662 1,017,851 
        accrued employee compensation
      923,147 912,103 914,067 964,615 960,332 977,088 223,719 460,024 556,963 754,621 727,743 943,248 704,925 1,021,740 764,748 783,449 512,173 874,589                     
        other current liabilities
      15,480 22,982 30,330 29,710 29,110 28,527 59,930 31,831 106,112 30,863 4,540 4,586 4,631 20,830 36,706 52,260 67,497 66,269 65,072 63,902 62,765 62,483   62,939 62,286 61,315 68,432 84,253          
        current liabilities held for sale
      7,422,727 7,476,254 8,741 211,173 287,290 3,830,041                                 
        total current liabilities
      8,589,152 8,748,377 11,933,588 13,029,222 12,448,726 16,201,548 12,384,438 18,697,274 16,793,854 14,572,603 11,384,681 24,229,094 13,923,606 15,430,393 17,055,305 8,407,224 4,150,526 5,885,838 2,638,340 2,545,820 1,996,622 2,082,525 2,332,005 1,968,248 2,048,354 1,688,250 1,313,005 2,184,736 1,132,511 916,936 1,543,293 1,227,252 2,152,187 2,716,649 1,657,619 1,002,584 802,911 1,035,764 
        long-term debt
      3,786,126 3,486,141    1,996,558 5,298,947 5,161,394 5,300,649 7,711,866 7,772,695 6,441,077 6,526,105 6,286,109 7,617,173 8,114,797 8,419,290 8,523,333 8,678,642 8,766,986 8,622,436 8,528,490 8,425,552 4,423,028 4,032,744 4,432,052 4,397,539 4,487,004 3,941,010 3,519,821 2,970,816 2,932,573 3,001,813 3,034,420 3,059,990 2,952,668 2,786,839 2,645,015 
        total liabilities
      12,375,278 12,234,518 11,933,588 13,037,043 12,464,205 18,221,088 17,713,714 24,092,760 22,336,739 22,534,710 19,357,232 30,871,150 20,651,814 21,919,729 24,876,874 16,727,586 12,776,550 14,633,229 11,558,084 11,570,632 10,893,290 10,901,342 11,063,731 6,713,004 6,418,095 6,473,110 6,079,283 7,056,247 5,473,456 4,436,757 4,514,109 4,159,825 5,154,000 5,751,069 4,717,609 3,955,252 3,589,750 3,680,779 
        commitments and contingencies
                                            
        stockholders' deficit:
                                            
        common stock, 0.001 par value...
                                            
        5,147,204 and 3,877,695 shares issued and outstanding at march 31, 2026
                                            
        and december 31, 2025, respectively
      5,147                                      
        additional paid-in capital
      387,331,517 386,368,222 386,361,538 386,354,487 386,337,769 386,297,611 386,237,887 386,172,255 386,103,358 385,998,213 385,879,364 385,691,274 385,585,097 385,388,684 385,279,809 385,172,168 385,063,351 384,852,107 384,763,523 384,674,939 384,459,964 263,629,116 201,402,983 171,102,440 170,957,969 156,241,363 156,022,668 155,803,946 149,702,936 142,707,957 138,333,891 138,262,298 137,629,187 126,718,186 126,681,495 126,644,804 126,580,621 101,581,724 
        accumulated deficit
      -389,463,095 -388,263,025 -374,125,213 -372,744,440 -369,371,403 -369,772,538 -285,656,698 -282,252,367 -231,738,126 -220,579,878 -212,154,904 -206,016,791 -199,508,045 -193,021,977 -186,952,677 -181,512,550 -175,976,508 -170,864,782 -164,796,661 -157,931,822 -152,701,085 -148,542,194 -142,425,299 -138,775,511 -135,251,827 -132,142,209 -128,723,452 -125,705,230 -121,678,498 -118,914,567 -116,490,472 -113,763,444 -110,982,295 -108,532,508 -105,869,259 -103,423,040 -101,329,604 -99,273,861 
        total stockholders' deficit
      -2,126,431                                      
        total liabilities and stockholders' deficit
      10,248,847                                      
        cash and cash equivalents
       501,295 951,434 729,569 1,366,328 230,362 500,434 728,339 2,592,467 8,203,869 16,767,070 42,842,280 72,776,543 101,638,557 127,008,620 118,888,889 75,509,793 88,454,988 118,179,653 132,345,351 210,899,434 95,751,160 38,989,366 10,021,394 14,749,746 2,798,744 6,412,921 10,400,795 7,630,376 2,990,196 1,030,671 3,518,806 6,839,389 492,861 4,717,821 7,991,382 25,472,604 3,324,609 
        non-current assets held for sale
                                            
        current debt
        7,910,684 8,505,992 1,092,641 1,261,039 349,312 5,330,124 3,024,575 795,300 756,559 2,406,147 2,377,781 2,387,231 709,597 688,390 657,828 627,365 619,552 501,553 378,791 259,939 152,501 140,288 150,730 163,155 149,069 139,274 90,200 71,613 59,636 58,377 59,260 49,794 55,223 53,089 18,249 17,913 
        long-term lease obligations
         7,821 15,479 22,982 30,329 234,092 242,236 250,241 199,856 200,979 202,103 203,227 204,396 205,565 206,734 224,058 241,102 257,826 274,232 290,327 306,174 321,728 336,997 352,808 368,739 384,507 399,935          
        stockholders' (deficit) equity:
                                            
        3,877,695 and 3,865,778 shares issued and outstanding at december 31, 2025
                                            
        and 2024, respectively
       3,878                                     
        accumulated other comprehensive loss
           -688,229 -513,405 -579,106 -521,771 -405,464 -539,204 -401,002 -512,348 -516,775 -589,909 -318,554 -286,748 -255,588 -242,863 -112,325 -187,219 -267,258 -490,153 -576,644 -742,145 -360,160 -440,738 -401,846 -486,635 -574,186 -327,102 -411,813 -326,002 -213,884 -243,188 -278,121 -300,558 -286,272 
        total stockholders' (deficit) equity
       -1,890,925                                     
        total liabilities and stockholders' (deficit) equity
       10,343,593                                     
        property, plant and equipment
        22,668,000 22,668,000 22,668,000 22,668,000 80,188,450 90,233,868 170,336,285 174,381,382 168,657,134 160,174,487 127,357,662 106,286,186 88,002,701 63,978,895 37,828,165 33,815,119 30,008,937 29,159,517 27,904,874 26,930,338 25,699,143 24,562,409 23,708,229 25,065,836 24,780,705 24,621,309 23,934,625 23,716,768 24,001,108 23,617,701 23,599,868 21,802,976 19,478,853 17,906,075 2,199,311 1,723,707 
        stockholders' equity:
                                            
        3,877,695 and 3,865,778 shares outstanding at september 30, 2025 and
                                            
        december 31, 2024, respectively
        3,878 3,878 3,869                                  
        total stockholders' equity
        12,240,203 13,613,925 16,970,235 15,840,710 100,071,650 103,344,648 153,847,318 165,016,718                             
        total liabilities and stockholders' equity
        24,173,791 26,650,968 29,434,440 34,061,798 117,785,364 127,437,408 176,184,057 187,551,428                             
        3,877,695 and 3,865,778 shares outstanding at june 30, 2025 and
                                            
        3,869,361 and 3,865,778 shares outstanding at march 31, 2025 and
                                            
        intangible assets
            194,158 197,584 201,010 204,436 207,861 211,287 214,713 218,139 221,565 224,991 228,417 231,842 235,268 238,694 242,120                  
        restricted cash
              1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 500,000 500,000 500,000 500,000 500,000                
        non-current liabilities held for sale
                                            
        3,865,778 and 3,847,022 shares outstanding at december 31, 2024 and
                                            
        2023, respectively
           3,866                                 
        inventory
            466,270 124,916 472,087 1,733,603 1,942,420 2,353,616 2,376,207 2,276,592 2,104,251 1,918,395 1,675,682 1,259,910 1,222,223 2,655,098 2,106,473 1,525,377 2,869,470 2,489,773 1,833,957 1,232,049 477,077 210,345 159,131 76,109 72,640 82,429 125,293 172,363 78,499 78,275 101,046  
        assets held for sale
            35,286,854 35,086,031                               
        other assets
            1,894 2,202 46,051 46,761 49,367 52,793 65,162 64,859 68,343 72,083 75,957 79,548 78,204 81,629 84,685 76,715 50,213 44,306 33,331 32,024 45,001 80,583 80,583 80,583 162,093 162,093 162,093 162,093 162,093 21,628 21,628 21,628 
        3,865,778 and 3,847,022 shares outstanding at september 30, 2024 and
                                            
        december 31, 2023, respectively
            3,866 3,866 3,857                              
        3,865,778 and 3,847,022 shares outstanding at june 30, 2024 and
                                            
        3,857,444 and 3,847,022 shares outstanding at march 31, 2024 and
                                            
        december 31, 2023 and 2022, respectively; 3,847,022 and 3,834,383 shares
                                            
        outstanding at december 31, 2023 and 2022, respectively
               3,847                             
        liabilities and stockholders’ equity
                                            
        stockholders’ equity:
                                            
        september 30, 2023 and december 31, 2022, respectively; 3,846,772 and 3,834,383
                                            
        shares outstanding at september 30, 2023 and december 31, 2022, respectively
                3,847                            
        total stockholders’ equity
                173,189,103 179,344,827 185,636,043 191,921,043 197,808,334 203,412,175 208,871,205 213,802,763 219,795,025 226,701,818 231,642,643 114,875,161 58,532,448 31,782,391 34,996,083 23,760,629 26,880,083 29,718,468 27,556,500 23,234,303 21,529,165 24,099,889 26,333,566 17,980,689 20,577,943 22,952,538 24,959,344 2,028,055 
        total liabilities and stockholders’ equity
                192,546,335 210,215,977 206,287,857 213,840,772 222,685,208 220,139,761 221,647,755 228,435,992 231,353,109 238,272,450 242,535,933 125,776,503 69,596,179 38,495,395 41,414,178 30,233,739 32,959,366 36,774,715 33,029,956 27,671,060 26,043,274 28,259,714 31,487,566 23,731,758 25,295,552 26,907,790 28,549,094 5,708,834 
        and december 31, 2022; 71,345,649 and 71,110,713 shares outstanding at june 30,
                                            
        2023 and december 31, 2022, respectively
                 71,346 71,339                          
        and december 31, 2022; 71,338,938 and 71,110,713 shares outstanding at march 31,
                                            
        marketable securities
                     29,354,888 103,365,156 101,773,781 79,632,028 71,693,675                   
        december 31, 2022 and 2021, respectively; 71,110,713 and 71,025,738 shares
                                            
        outstanding at december 31, 2022 and 2021, respectively
                   71,111                         
        september 30, 2022 and december 31, 2021, respectively; 71,110,713 and 71,025,738
                                            
        shares outstanding at september 30, 2022 and december 31, 2021, respectively
                    71,111                        
        june 30, 2022 and december 31, 2021, respectively; 71,110,713 and 71,025,738 shares
                                            
        outstanding at june 30, 2022 and december 31, 2021, respectively
                     71,111                       
        december 31, 2021; 71,109,701 and 71,025,738 shares outstanding at march 31, 2022
                                            
        and december 31, 2021, respectively
                      71,110                      
        2020; 71,025,738 and 55,497,133 shares outstanding at december 31, 2021 and 2020, respectively
                       71,026                     
        71,025,738 (2020: 55,497,133) shares outstanding
                        71,026                    
        71,025,738 and 55,497,133 shares outstanding as of june 30, 2021 and december 31,2020, respectively
                         71,026                   
        70,983,145 (2020: 55,497,133) shares outstanding
                          70,983                  
        other receivables
                           46,678 62,034 57,369 82,873 55,198 73,340 109,896 136,903 115,982 81,822 101,328 217,536 183,926 219,334 161,039 92,455 164,743 
        definite lived intangible assets
                           143,885                 
        indefinite lived intangible assets
                           101,661                 
        55,497,133 (2019: 21,635,365) shares outstanding
                           55,497                 
        definite-lived intangible assets
                            147,311 150,736 154,162 157,588 161,014 164,440 167,866 171,292 174,717 178,143 181,569 184,995 188,421 191,847 195,273 198,698 
        indefinite-lived intangible assets
                            101,661 101,661 101,661 101,661 191,800 191,800 191,800 191,800 191,800 191,800 191,800 191,800 191,800 191,800 191,800 191,800 
        current lease liabilities and other
                            62,627 63,836               
        44,916,926 (2019: 21,635,365) shares outstanding
                            44,917                
        32,105,684 (2019: 21,635,365) shares outstanding
                             32,106               
        32,085,684 (2019: 21,635,365) shares outstanding
                              32,086              
        21,635,365, (2018: 15,098,837) shares outstanding
                               21,635             
        certificate of deposit
                                12,712 12,866 12,606 12,361 13,040 12,820 13,045 13,422 13,489 12,972 10,749 10,666 
        21,605,322 (2018: 15,098,837) shares outstanding
                                21,605            
        21,598,555 (2018: 15,098,837) shares outstanding
                                 21,598           
        18,697,477 (2018: 15,098,837) shares outstanding
                                  18,697          
        15,098,837, (2017: 8,895,094) shares outstanding
                                   15,099         
        12,848,376 (2017: 8,895,094) shares outstanding
                                    12,848 12,848       
        12,675,533 (2017: 8,895,094) shares outstanding
                                      12,676      
        8,895,094 (2016: 6,463,936) shares outstanding
                                       8,895 8,895 8,895   
        8,885,009 (2016: 6,463,936) shares outstanding
                                          8,885  
        stockholders’ equity
                                            
        6,463,935 (2015: 5,247,604) shares outstanding
                                           6,464 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 
                                             
          operating activities
                                             
          net income
        -1,200,070    401,135                                 
          adjustment to reconcile net loss to net cash from
                                             
          operating activities:
                                             
          share-based compensation
        5,014 6,684 7,051 16,727 40,161 59,724 65,632 68,906 105,155 118,849 120,591 106,184 196,641 108,874 107,641 107,280 211,328 88,584 88,584 87,354 129,715 52,727 74,720 103,891 205,353 218,725 196,736 318,218 138,498 71,714 71,593 71,543 48,546 36,691 36,691 36,691 12,061 
          loan forgiveness
         -2,008,046                                 
          paid in kind interest
        299,985                                     
          changes in operating assets and liabilities:
                                             
          prepaid expenses and other assets
        34,129 203,059 157,289 16,285 -518,245 235,588 107,940 492,992 441,015 1,945,685 -344,912 -1,070,176 -155,167 1,925,077 408,308 -2,743,834 -139,671 -344,118 81,566 -812,173 -63,966 444,063 -122,982 -330,987 -73,944 103,346 195,416 -294,324 55,504 79,072 79,310 -238,135 369,621 -282,616 -30,928 -88,043 -191,015 
          accounts payable and accrued liabilities
        -170,269 -2,127,407 -352,724 568,555 -259,975 -96,051 -356,291 731,069 335,835 -208,710 -590,335 564,211 184,232 367,349 -2,074,589 1,712,284 -6,949 223,439 160,393 121,366 -274,486 126,016 86,261 -59,676 339,818  -576,668 668,728 253,509 -311,931 128,359 -274,933 -508,423 496,846 167,619 248,895 -287,597 
          accrued employee compensation
        11,044 -1,964 -50,548 4,283 -16,756 1,171,581 -236,305 -96,939 -197,658 26,878 -215,505 238,323 -316,815 256,992 -18,701 271,276 -362,416                     
          net cash from operating activities
        -1,020,167 -3,178,269 -1,651,340 -1,548,321 -2,361,726 -1,163,120 -4,001,489 -4,325,690 -4,372,677 -5,773,251 -6,216,708 -6,104,733 -6,141,553 -3,053,939 -6,696,483 -5,929,994 -5,326,414 -5,360,967 -4,653,459 -5,939,439 -4,518,394 -3,703,364 -3,612,169 -4,038,578 -2,934,710 -2,960,571 -3,082,011 -3,073,485 -2,132,680 -2,347,505 -2,134,882 -2,867,301 -2,467,077 -2,425,138 -2,278,600 -1,893,018 -2,504,022 
          capital expenditures
        -1,722,459 -1,229,728 -1,208,183 -1,335,096 -1,051,542 -897,146 -691,351 -491,978 -899,214 -469,181 -456,436 -634,430 -336,129 -1,005,129 -2,034,048 -1,658,080 -1,041,258 -15,736,703 -457,223 
          free cash flows
        -1,020,167 -3,178,269 -1,651,340 -1,548,321 -2,361,726 -1,163,120 -4,001,489 -4,325,690 -4,372,677 -5,773,251 -6,216,708 -6,104,733 -6,141,553 -3,053,939 -6,696,483 -5,929,994 -5,326,414 -5,360,967 -6,375,918 -7,169,167 -5,726,577 -5,038,460 -4,663,711 -4,935,724 -3,626,061 -3,452,549 -3,981,225 -3,542,666 -2,589,116 -2,981,935 -2,471,011 -3,872,430 -4,501,125 -4,083,218 -3,319,858 -17,629,721 -2,961,245 
          investing activities
                                             
          proceeds from asset sales
         24,000 2,473,205 911,563 3,721,116 987,161                                
          net cash from investing activities
         24,000 2,473,205 911,563 3,721,116 774,133 8,683,232 -724,848 -1,169,203 -2,632,950 -19,669,592 -23,655,009 -22,935,252 -22,593,331 14,976,966 49,434,003 -7,467,583 -23,720,189 -9,666,944 -72,932,373 -1,219,193 -1,693,296 -1,056,166 -908,299 419,350 -645,365 -899,202 -460,646 -456,423 -727,956 -336,116 -984,557 -2,032,875 -1,810,802 -1,041,258 -15,736,703 -457,223 
          financing activities
                                             
          repayment of term debt
         -575,959 -600,000 -232,194 -51,186 -6,551,891 -2,811,448 -184,019 -184,121 -182,315 -180,312 -179,392 -161,300 -160,270 -159,296 -159,304 -152,575 -39,927 -40,715 -38,885 -20,964 -8,600 -1,871 -39,391 -28,801 -29,164 -18,218 -9,619 -12,178 -14,567 -14,702 -14,168 -12,135 -12,272 -6,842 -4,563 
          proceeds from issuance of common stock and warrants
        959,550                                     
          net cash from financing activities
        959,550 2,704,130 -600,000 -232,194 124,389 -4,909,926 2,188,552 -66,727 -160,604 -182,315 -180,312 214,764 272,590 -160,270 -115,420 -159,304 -152,575 160,148 306,207 120,864,854 62,163,022 34,138,414 219,259 14,482,313 -28,800 -7,172 6,292,125 7,226,577 5,064,283 -14,567 547,038 10,852,068 -12,135 -12,272 151,709 25,110,452 
          effect of exchange rate changes on cash and cash equivalents
                             -734 -15,951 8,198 511 12,425 2,706 -29,297 -2,570 -15,763 -5,588 23,115 58,569 -3,210 -1,212 
          net change in cash
        -60,617                                     
          cash at beginning of period
        501,295                                     
          cash at end of period
        440,678                                     
          supplemental disclosure of cash flow information and non-cash transactions:
                                             
          interest paid in cash from discontinued operations
        145,701 1,813   16,903                                 
          property and equipment included in accounts payable and accrued liabilities
          718,279 -7,290,262 9,137,864 -272,110 -945,980 -1,040,775 11,464,684 3,370,903 -10,381,973 9,466,039 9,216,027 -3,930,927 10,737,905 2,251,328 1,507,514 2,719,593 -182,072 306,427 82,068 -493,744 279,109 -19,649 257,884 90,729 -303,267 343,615 79,193 -319,119 182,361 -646,072 976,208 563,957    
          net loss
         -14,137,812 -1,380,773   -84,115,840 -3,404,331 -50,514,241 -11,158,248 -8,424,974 -6,138,113 -6,508,746 -6,486,068 -6,069,300 -5,440,127 -5,536,042 -5,111,726 -6,068,121 -6,864,839 -5,230,737 -4,158,891 -6,116,895 -3,649,788 -3,523,684 -3,109,618 -3,418,757 -3,018,222 -4,026,732 -2,763,931 -2,424,095 -2,727,028 -2,781,149 -2,449,787 -2,663,249 -2,446,219 -2,093,436 -2,055,743 
          depreciation and amortization
             35,844 145,775 146,973 575,544 550,971 540,784 534,750 531,726 523,402 513,089 497,729 490,563 479,502 450,220 435,657 422,185 412,335 380,668 353,734 347,859 357,426 351,880 291,288 285,308 285,669 284,072 206,196 67,450 47,717 45,660 44,696 46,873 
          long-lived asset impairment
         13,153,000 68,547   81,093,181 44,468,222 4,265,000                             
          other non-cash items
         -273,829    -5,564                                
          inventory
             458,417 -335,633 343,485 1,257,290 214,533 407,103 25,147 -99,936 -170,319 -196,241 -249,296 -411,794 -35,934 1,426,189 -545,268 -577,154 1,356,721 -377,051 -651,730 -610,200 -753,506 -266,579 -50,979 -83,158 -3,941 9,241 42,609 46,047 -91,492 -224 22,771 -101,046 
          purchases of and deposits on property, plant and equipment
             -213,028 -673,547 -874,130 -1,169,203 -2,632,950 -19,669,592 -23,655,705 -22,931,293 -22,593,331                        
          proceeds from issuance of debt
             175,575 1,641,965 5,000,000 117,292 23,517 394,156 433,890   200,075 219,258 187,120 4,000,000   524,650 376,117     131,049 125,758 
          net change in cash and cash equivalents
         -450,139 221,865                     -4,728,352 11,951,002 -3,626,538 -3,987,874 2,770,419 4,640,180 1,959,525 -2,488,135 -3,320,583 6,346,528 -4,224,960 -3,273,561 -17,481,222 22,147,995 
          cash and cash equivalents at beginning of period
                             2,798,744 12,361 2,990,196 492,861 3,324,609 
          cash and cash equivalents at end of period
         -450,139 221,865                                   
          interest paid in cash from continuing operations
                                             
          non-cash conversion of accounts payable to current debt
                                           
          adjustment to reconcile net income to net cash from
                                             
          effect of exchange rate changes on cash, cash equivalents and restricted cash
            8,770 -5,474 278 -2,142 -2,795 3,604 -6,595 5,791 27 4,617 -482 -9,493 8,106 9,066 -5,443 11,522 21,007                 
          net change in cash, cash equivalents and restricted cash
            1,135,966 -270,072 -227,905 -2,864,128 -5,611,402 -8,563,201 -26,075,210 -29,934,263 -28,862,014 -25,370,063 8,119,731 43,379,096 -12,945,195 -29,224,665 -14,165,698 -78,554,083 115,148,274 56,761,794                
          cash, cash equivalents and restricted cash at beginning of period
            230,362 9,203,869 102,638,557 89,454,988 96,251,160                
          cash, cash equivalents and restricted cash at end of period
            1,366,328 -270,072 -227,905 -2,864,128 3,592,467 -8,563,201 -26,075,210 -29,934,263 73,776,543 -25,370,063 8,119,731 43,379,096 76,509,793 -29,224,665 -14,165,698 -78,554,083 211,399,434                 
          reconciliation of cash, cash equivalents and restricted cash reported
                                             
          in the consolidated balance sheet:
                                             
          cash and cash equivalents
            1,366,328 -270,072 -227,905 -1,864,128 2,592,467 -8,563,201 -26,075,210 -29,934,263 72,776,543 -25,370,063 8,119,731 43,379,096 75,509,793 -29,724,665 -14,165,698 -78,554,083 210,899,434                 
          restricted cash
                1,000,000 1,000,000 1,000,000 500,000 500,000                 
          total cash, cash equivalents and restricted cash
            1,366,328 -270,072 -227,905 -2,864,128 3,592,467 -8,563,201 -26,075,210 -29,934,263 73,776,543 -25,370,063 8,119,731 43,379,096 76,509,793 -29,224,665 -14,165,698 -78,554,083 211,399,434                 
          other investing activities
                 696 -3,959   -11,010 -8,353 -6,440 -11,153 -1,307    13         
          interest paid in cash
              1,030,949 956,129 205,173 104,641 60,067 61,991 62,439 64,896 68,176 70,453 71,037 74,461 75,062 75,848 73,685 67,618 30,217 13 17,045 17,505 17,933 14,212 13,338 6,403 5,169 5,283 5,402 5,407 5,597 5,253 5,280 
          other non-cash charge
               33,843 3,390 3,517 3,679 5,574 3,834 3,986 4,137 10,609 4,251 4,393 4,428 4,362 4,203                 
          maturities of marketable securities
                     29,387,258                       
          purchases of marketable securities
                     -45,915,851 -1,705,440 -22,166,752 -7,944,485                   
          proceeds from the exercise of stock options and warrants
                       127,664 1,596,182      21,992 250,424        
          proceeds from the issuance of common stock
                         119,120,437 60,389,314 29,714,597 14,521,704         24,989,257 
          purchases and deposits on property, plant and equipment
                       -24,710,561 -5,762,143                     
          supplemental disclosure of cash flow information and
                                             
          non-cash transactions:
                                             
          purchases of property, plant and equipment
                                             
          deposits on equipment purchases
                                             
          proceeds from sale equipment
                                             
          proceeds from legal settlement
                             1,014,008             
          payment of debt issuance costs
                                            
          purchase of property, plant and equipment
                          -1,722,459 -1,229,728 -1,208,183 -1,335,096 -1,051,542 -897,146 -691,351 -491,978 -899,214 -469,181 -456,436 -634,430 -336,129 -1,005,129 -2,034,048 -1,658,080 -1,041,258 -15,736,703 -457,223 
          proceeds from sale of asset held for sale
                                98,000             
          gain on sale of equipment
                                             
          loss on asset held for sale
                                             
          impairment loss
                                             
          other non-cash charges
                             4,188                
          other receivables
                             17,481 -3,548 29,274 -33,978 19,122 35,426 28,864 -18,410 -41,141 19,571 117,153 -39,371 31,906 -51,199 -64,592 72,445 
          proceeds from sale of equipment
                             1,816   7,300            
          proceeds from exercise of stock options and warrants
                                             
          acquisition of equipment under debt arrangement
                                     -487 -569 -787 75,911     
          gain on disposal of equipment
                                 -3,585   -1,488 -10,585 -1,160     
          effect of exchange rate changes on cash
                                             
          cash, cash equivalents and restricted cash at the end of period
                                             
          cash and cash equivalents at the end of period
                               -4,728,352 14,749,746 -3,614,177 -3,987,874 2,770,419 7,630,376 1,959,525 -2,488,135 -3,320,583 6,839,389 -4,224,960 -3,273,561 -17,481,222 25,472,604 
          accounts payable, accrued liabilities and other liabilities
                                             
          proceeds from the issuance of common stock and warrants
                                 5,785,693 6,609,655 -2 10,616,048     
          proceeds on sale of equipment
                                      13 20,572 1,173     
          non-cash interest and other expenses
                                             
          payment of patent costs
                                             
          proceeds from the issuance of convertible debt
                                             
          conversion of convertible debt and accrued interest to common stock
                                             
          proceeds from the exercise of stock warrants
                                        250,188     
          non-cash interest expense
                                             
          proceeds from exercise of stock options
                                             
          proceeds from the exercise of stock options
                                            
          property and equipment included in accounts payable
                                             
          acquisition of equipment through vendor payables
                                            54,297 
          conversion of convertible debt and accrued interest to
                                             
          common stock
                                             
          acquisition of equipment through vendor payments